Thi s im DSM Venturing Corporate VC of DS M
DS M Venturing – Corporate VC of DS M DSM company profile DS M is a global science-based company active in health, nut rition and materials. By connecting our unique competences in Life S ciences and Materials S ciences we are driving economic prosperity, environmental progress and social advances t o create sustainable value for all stakeholders. We deliver innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, pharmaceut icals, medical devices, automot ive, paints, elect rical and elect ronics, life protect ion, alternative energy and bio-based materials. DS M has annual net sales of around € 9 billion. Our company is headquartered in the Netherlands, and we employ approximately 22,000 people across the globe. Page 1
DS M Venturing – Corporate VC of DS M DSM in motion: driving focused growth People - Planet - Profit: creating value along three dimensions Page 2
DS M Venturing – Corporate VC of DS M Innovation boost 2005 - 2010 Proud to have achieved • € 1bn sales from innovation • Increased speed of innovation • S ett ing up EBAs • S trong innovation infrastructure/ culture • External recognition as leading innovator Proven our ability to accelerate the pace of innovation Page 3
DS M Venturing – Corporate VC of DS M Innovation in new strategy Next level aspiration • Innovation sales: > 20% of t otal sales • Sales EBAs (BMM/ BP&S): > € 1bn • Innovation focus on platforms to 20% • Value creat ion via best practices • S et up China and India Innovation Centers From 12% Innovation sales Doubling innovation sales Page 4
DS M Venturing – Corporate VC of DS M Focused platforms and a well-stocked pipeline Global Climate Health shifts & Energy & Wellness Innovation Platforms (Examples - Business Groups) Bio Bio-based Sports & Life (Bio) Food/feed processing clean / green Protection Manufacturing ingredients ingredients materials Materials Emerging Business Areas ( DSM Innovation Center) Bio-based Advanced Surfaces Biomedical Products & Services Page 5
DS M Venturing – Corporate VC of DS M Accelerating and supporting innovation DSM Innovation Center New Business Development Enablers Excellence in Innovation EBA Biomedical EBA Bio-based CTO Office Products & S ervices Licensing EBA Advanced S urfaces Business Incubator Venturing Page 6
DS M Venturing – Corporate VC of DS M DSM Venturing - Mission DSM ´ s competence center for external (VC) participations aimed at boosting innovation & growth Window to the world Explore new emerging markets, technologies and products in order to M ´ s product port folio, technology toolbox and business model's enhance DS Strategic value Add value int ernally and ext ernally t hrough facilitating strategic co- operations with start-ups Financial return Create value by investing in and divesting start-up companies Page 7
DS M Venturing – Corporate VC of DS M When does DSM Venturing invest? S ales Risk High High Investment & Risk DSM Venturing "Angels" Public/ PE Sales Financing Grants gap Venture Capital Investment amount s Low Low Emerging Proof of principle Commercializat ion Expansion Technology Time Page 8
DS M Venturing – Corporate VC of DS M Summary Investment scope • Companies in early st age to expansion stage, act ive in DSM strategic scope • Typical initial investment: € 0.5 – 5 mln • Minorit y part icipat ions typically a 10 - 25% stake • Recognized pot ent ial for strat egic cooperation wit h DS M Businesses • Represent ation in board of start-up • Global (focus on US A, EU) Page 9
DS M Venturing – Corporate VC of DS M Track Record • 40 direct investments since 2001; 23 st ill active in our current portfolio • 17 divested: – 2 acquired by DS M businesses (LTP and TCG) – 2 sold to third party acquirers (Morphotek and OPM) – 2 sold back to the founders (Creagri and Terreco) – 1 successful IPO (S peedel) – 10 failed and were dissolved, liquidated, wound down • Net financial result is positive – i.e. ‘ free’ option generation! • Part nerships realized with 30 port folio companies in various forms and degrees (feasibility studies, j oint development, licensing, distribut ion/ marketing relations, supply relations) • In addition, DS M Venturing facilitated similar partnerships with > 50 other start-ups which it scouted but did not invest in • We scouted and screened more than 3000 companies which provided useful insights and complementary window-on-the-world for our businesses Page 10
Thi s im Portfolio Direct Investments Life Sciences Material Sciences
For personal use only Venturing team IanFreelance Pieter Wolters Greg McParland S enior Investment Manager EU Managing Direct or S enior Investment Manager US A Marcel Kloosterman Casper Bruens Invest ment Manager S enior Investment Manager Page 12
Recommend
More recommend
